UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

Pilot evaluation of the text4baby mobile health program

BMC public health, 2012-11, Vol.12 (1), p.1031-1031, Article 1031

2012

Link zum Volltext

Verfügbarkeit prüfen

Bayesian additional evidence for decision making under small sample uncertainty

BMC medical research methodology, 2021-10, Vol.21 (1), p.1-221, Article 221

2021

Link zum Volltext

Verfügbarkeit prüfen

The Saleema initiative in Sudan to abandon female genital mutilation: Outcomes and dose response effects

PloS one, 2019-03, Vol.14 (3), p.e0213380-e0213380

2019

Link zum Volltext

Verfügbarkeit prüfen

RAS Amplification as a Negative Predictor of Benefit from Anti‐EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer

The oncologist (Dayton, Ohio), 2021-06, Vol.26 (6), p.469-475

2021

Link zum Volltext

Verfügbarkeit prüfen

Federally Qualified Health Center Substitution of Local Health Department Services

American journal of preventive medicine, 2017-10, Vol.53 (4), p.405-411

2017

Link zum Volltext

Verfügbarkeit prüfen

ERBB2 copy number (CN) as a quantitative biomarker for real-world (RW) outcomes to anti-HER2 therapy in advanced gastroesophageal adenocarcinoma (adv GEA)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4045-4045

2021

Link zum Volltext

Verfügbarkeit prüfen

Brand equity and willingness to pay for condoms in Zimbabwe

Reproductive health, 2011-10, Vol.8 (1), p.29-29, Article 29

2011

Link zum Volltext

Verfügbarkeit prüfen

Adherence to clinical preventive services guidelines: Population-based online randomized trial

SSM - population health, 2015-12, Vol.1 (C), p.48-55

2015

Link zum Volltext

Verfügbarkeit prüfen

Effects of the truth FinishIt brand on tobacco outcomes

Preventive medicine reports, 2018-03, Vol.9, p.6-11

2018

Link zum Volltext

Verfügbarkeit prüfen

Concordance of HER2+ status by IHC/ISH and ERBB2 status by NGS in a real-world clinicogenomic database and analysis of outcomes in patients (pts) with metastatic breast cancer (mBC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1036-1036

2021

Link zum Volltext

Verfügbarkeit prüfen

Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic Databases

Cancer epidemiology, biomarkers & prevention, 2022-06, Vol.31 (6), p.1195-1201

2022

Link zum Volltext

Verfügbarkeit prüfen

CtDNA shed as a tool to select immune checkpoint inhibitors (ICPI) with or without chemotherapy for patients (pts) with advanced non–small cell lung cancer (aNSCLC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9045-9045

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 09: Cancers with NTRK gene fusions: Molecular characteristics and prognosis

Clinical cancer research, 2020-06, Vol.26 (12_Supplement_1), p.9-9

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 864: Changes over time in real-world next-generation sequencing (NGS) test use in patients (pts) with advanced non-small cell lung cancer (aNSCLC)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.864-864

2021

Link zum Volltext

Verfügbarkeit prüfen

TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting

Targeted oncology, 2021-05, Vol.16 (3), p.389-399

2021

Link zum Volltext

Verfügbarkeit prüfen

Perceptions of the food shopping environment are associated with greater consumption of fruits and vegetables

Public health nutrition, 2012-06, Vol.15 (6), p.1124-1129

2012

Link zum Volltext

Verfügbarkeit prüfen

Tumor mutational burden (TMB) measurement from an FDA-approved assay and real-world overall survival (rwOS) on single-agent immune checkpoint inhibitors (ICI) in over 8,000 patients across 24 cancer types

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2503-2503

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-world (RW) outcomes for advanced non-small cell lung cancer (aNSCLC) patients (pts) with EGFR exon 19 deletions (x19del) stratified by deletion size

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9591-9591

2020

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and outcomes of real-world (RW) patients (pts) with microsatellite instability-high (MSI-H) solid tumors treated with pembrolizumab monotherapy (P) after FDA approval

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3060-3060

2020

Link zum Volltext

Verfügbarkeit prüfen

Initial outcomes from a 4-week follow-up study of the Text4baby program in the military women's population: randomized controlled trial

Journal of medical Internet research, 2014-05, Vol.16 (5), p.e131-e131

2014

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of the Adelante community social marketing campaign for Latino youth

Health education research, 2019-10, Vol.34 (5), p.471-482

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of real-world agreement between HER2 expression and ERBB2 amplification with trastuzumab therapy benefit in advanced gastric/esophageal (adv GE) cancer patients (pts)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.310-310

2020

Link zum Volltext

Verfügbarkeit prüfen

Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling

Lung cancer (Amsterdam, Netherlands), 2020-10, Vol.148, p.69-78

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of chemotherapy use, cost, and survival in patients with metastatic colorectal cancer in Western Washington and British Columbia

Journal of clinical oncology, 2018-06, Vol.36 (18_suppl), p.LBA3579-LBA3579

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(43)
Humans
(30)
Female
(22)
Oncology
(13)
Male
(12)
Adolescent
(10)
Adult
(10)
Public, Environmental & Occupational Health
(9)
Health Promotion - Methods
(8)
Middle Aged
(8)
Orthopedics
(7)
Technology
(7)
Young Adult
(7)
Care And Treatment
(6)
Social Sciences
(6)
Analysis
(5)
Animals
(5)
Brand Equity
(5)
Breast Cancer
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pilot evaluation of the text4baby mobile health program

Bayesian additional evidence for decision making under small sample uncertainty

The Saleema initiative in Sudan to abandon female genital mutilation: Outcomes and dose response effects

RAS Amplification as a Negative Predictor of Benefit from Anti‐EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer

Federally Qualified Health Center Substitution of Local Health Department Services

ERBB2 copy number (CN) as a quantitative biomarker for real-world (RW) outcomes to anti-HER2 therapy in advanced gastroesophageal adenocarcinoma (adv GEA)

Brand equity and willingness to pay for condoms in Zimbabwe

Adherence to clinical preventive services guidelines: Population-based online randomized trial

Effects of the truth FinishIt brand on tobacco outcomes

Concordance of HER2+ status by IHC/ISH and ERBB2 status by NGS in a real-world clinicogenomic database and analysis of outcomes in patients (pts) with metastatic breast cancer (mBC)

Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic Databases

CtDNA shed as a tool to select immune checkpoint inhibitors (ICPI) with or without chemotherapy for patients (pts) with advanced non–small cell lung cancer (aNSCLC)

Abstract 09: Cancers with NTRK gene fusions: Molecular characteristics and prognosis

Abstract 864: Changes over time in real-world next-generation sequencing (NGS) test use in patients (pts) with advanced non-small cell lung cancer (aNSCLC)

TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting

Perceptions of the food shopping environment are associated with greater consumption of fruits and vegetables

Tumor mutational burden (TMB) measurement from an FDA-approved assay and real-world overall survival (rwOS) on single-agent immune checkpoint inhibitors (ICI) in over 8,000 patients across 24 cancer types

Real-world (RW) outcomes for advanced non-small cell lung cancer (aNSCLC) patients (pts) with EGFR exon 19 deletions (x19del) stratified by deletion size

Characteristics and outcomes of real-world (RW) patients (pts) with microsatellite instability-high (MSI-H) solid tumors treated with pembrolizumab monotherapy (P) after FDA approval

Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study

Initial outcomes from a 4-week follow-up study of the Text4baby program in the military women's population: randomized controlled trial

Outcomes of the Adelante community social marketing campaign for Latino youth

Association of real-world agreement between HER2 expression and ERBB2 amplification with trastuzumab therapy benefit in advanced gastric/esophageal (adv GE) cancer patients (pts)

Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling

Comparison of chemotherapy use, cost, and survival in patients with metastatic colorectal cancer in Western Washington and British Columbia

Suchergebnisse filtern